Skip to main content
. 2020 Sep 15;79(10):1054–1064. doi: 10.1093/jnen/nlaa090

TABLE.

Overview of the Quantitative Analysis

Control
Type A Cortical Tuber
Type B Cortical Tuber
Type C Cortical Tuber
Perituberal Cortex
Statistical Significance
Total n Available n Median Min Max Total n Available n Median Min Max Total n Available n Median Min Max Total n Available n Median Min Max Total n Available n Median Min Max p Value
T-cells/mm² [CD3] Gray matter 39 7 2.78 0.45 3.54 11 11 4.12 1.00 22.07 20 16 11.26 0.64 43.69 15 15 11.34 0.26 76.52 9 7 2.77 0.98 6.84 0.011
T-cells/mm² [CD3] White matter 39 7 4.22 0.80 9.70 11 11 13.76 0.33 31.66 20 16 20.47 3.59 80.94 15 15 17.77 1.96 128.96 9 7 12.71 1.46 32.04 0.011
Neurons/mm² [NeuN] Gray matter 39 7 1499.90 1059.00 1842.73 11 11 909.64 227.98 1491.58 20 17 548.63 125.10 1404.76 15 15 550.64 224.04 1805.36 9 8 942.93 406.39 1521.70 0.001
Neurons/mm² [NeuN] White matter 39 7 1.60 0.20 10.40 11 11 38.44 9.65 123.71 20 17 51.78 5.63 864.08 15 15 35.94 10.80 147.40 9 8 46.15 10.52 123.40 0.001
Microglial activation % [Cr3/43] Gray matter 39 7 0.88 0.17 2.12 11 11 0.61 0.09 30.37 20 16 2.33 0.39 26.66 15 15 2.23 0.04 18.91 9 9 0.71 0.01 9.05 0.144
Microglial activation % [Cr3/43] White matter 39 7 0.92 0.52 3.91 11 11 1.49 0.44 7.68 20 16 2.84 0.50 12.04 15 15 2.33 0.10 14.02 9 9 1.35 0.76 5.45 0.548
Gliosis % [GFAP] Gray matter 11 9 2.40 0.09 44.21 20 17 19.87 0.27 56.04 15 15 12.52 1.43 73.13 9 8 1.42 0.10 12.08 0.006
Gliosis % [GFAP] White matter 11 9 27.97 4.11 88.15 20 17 18.41 4.71 64.93 15 15 11.59 1.34 62.49 9 8 13.31 5.93 56.73 0.255
Oligodendroglia/mm² [olig2] Gray matter 39 18 243.50 158.88 394.88 11 10 80.42 29.68 477.66 20 16 85.06 32.54 449.56 15 15 122.47 56.03 520.68 9 6 83.23 23.13 120.35 0.002
Oligodendroglia/mm² [olig2] White matter 39 31 517.00 249.66 681.50 11 10 412.36 145.02 624.94 20 16 234.40 89.92 818.71 15 15 237.28 95.03 895.57 9 7 590.11 176.37 907.39 0.001
Myelin % [MBP] Gray matter 39 14 0.11 0.00 10.37 11 9 0.51 0.07 1.73 20 15 1.79 0.02 9.01 15 14 0.81 0.08 9.35 9 7 1.06 0.43 6.45 0.106
Myelin % [MBP] White matter 39 28 93.36 56.98 99.00 11 10 44.62 0.80 84.76 20 16 11.24 0.03 79.77 15 14 7.76 0.13 61.64 9 7 73.02 65.34 90.01 <0.001
Myelin 2% [MOBP] Gray matter 39 4 4.96 3.05 5.73 11 2 1.31 1.01 1.60 20 6 10.55 0.05 25.49 15 4 12.32 6.88 18.70 9 2 3.43 3.20 3.66 0.086
Myelin 2% [MOBP] White matter 39 15 68.00 7.00 100.00 11 2 27.03 16.93 37.13 20 6 4.01 0.05 17.12 15 4 2.28 0.81 18.26 9 2 15.05 0.44 29.66 0.002
axons % [SMI31] White matter 39 7 67.30 24.10 77.70 11 4 53.91 29.91 58.60 20 2 30.04 24.97 35.10 15 2 47.73 41.80 53.66 9 3 34.65 23.41 83.43 0.126
Nodes of Ranvier IOD [CASPR] White matter 39 5 5648.66 1831.33 9305.75 20 2 1483.77 956.88 2010.66 15 3 1368.21 1129.60 1563.58 0.016

All values are represented in median, minimum, and maximum. The total number of cases within the subgroup is shown as well as the number of cases available for the specific analysis. Significance level shown based on Kruskal-Wallis test except for [SMI31] and [CASPR], these are based on Mann-Whitney-U testing. Values considered significant < 0.05.

WM, white matter; GM, gray matter; olig2, oligodendroglia; MOBP, myelin associated oligodendrocyte basic protein; MBP, myelin basic protein; GFAP, glial fibrillary acidic protein; n, number; min, minimum; max, maximum.